InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by PERRY GREGORY D, Director. Insider active across 3 companies, notably Kala Pharmaceuticals, Inc.. Cumulatively, 7 disclosures have been published. Activity tracked since 17 June 2021. The latest transaction was disclosed on 11 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
7 of 7 declarations
Gregory D. Perry is a Board Member at Kala Pharmaceuticals, Inc. He is involved in the governance of the company, bringing his expertise to guide strategic decisions and ensure regulatory compliance.